Faruqi & Faruqi, LLP Reaches Settlement On Behalf Of Investors In Acadia Pharmaceuticals Inc.

Faruqi & Faruqi, LLP is pleased to announce that on March 13, 2017, Lead Plaintiffs, on behalf of themselves and a class of all persons who purchased or otherwise acquired publicly-traded ACADIA common stock and/or call options in the United States or on the NASDAQ Global Select Market during the period between November 10, 2014 and March 11, 2015, both dates inclusive, reached a settlement with ACADIA Pharmaceuticals Inc., Uli Hacksell, Stephen R. Davis, and Roger G. Mills (“Defendants”), whereby Defendants will pay $2,925,000 in cash to Class Members in exchange for a release of the claims against them.  Lead Plaintiffs have moved for preliminary approval of the settlement from the Court.  If the Court preliminarily approves the settlement, notice will be sent to Class Members to advise them of their rights to participate in, object to, or seek exclusion from the settlement.